Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
Background: Cardiotoxicity is one of the most serious chronic complications of anthracyclines therapy. Assessment of the left ventricular ejection fraction (LVEF) fails to detect subtle cardiac dysfunction of left ventricular (LV). This study aimed to detect and evaluate new parameters of subclinica...
Main Authors: | Hui-Min Hu, Xiao-Lin Zhang, Wei-Ling Zhang, Dong-Sheng Huang, Zhong-Dong Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2018-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=12;spage=1450;epage=1456;aulast=Hu |
Similar Items
-
Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01) -
Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01) -
Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
by: Francesco Venturelli, et al.
Published: (2018-09-01) -
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
by: Xi Zhou, et al.
Published: (2023-10-01) -
Longitudinal strain analysis for assessment of early cardiotoxicity during anthracycline treatment in childhood sarcoma: A single center experience
by: Maria Sjöborg Alpman, et al.
Published: (2023-09-01)